ION-547 | m-entrepreneurship.com

Product Name :
ION-547

Search keywords :
HAE

drugId :
null

Target Vo:
Coagulation factor XII

Target Vo Short Name :
F12

Moa_Name:
Coagulation factor XII expression inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
Ionis Pharmaceuticals Inc

Active Indication_Name:
Thrombosis

In Active Indication_Name:
Cardiovascular Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fascin Antibody
FKBP52 Antibody
pVHL Antibody: pVHL Antibody is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to pVHL. It can be used for IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts